Muc-1 receptor targeted nano-liposome containing peptide-drug-nanocage for breast cancer and cancer stem cell

Project Title

Partner Organisations

Direct Benefit Transfer

Internal ID

S/DBT/SUG/20190031

Principal Investigator

Status

Closed

Start Date

October 22, 2019

End Date

March 31, 2022

Organisations

Keywords